medline.ch Onkologie Blut

	Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study. Leukemia Rinaldetti S, Chepeleva M, Hedblom A, Sticht C, Muciek M, Panayiotidis P, Richter J, Olsson-Strömberg U, Nowak D, Nowak V, Ljungman P, von Bubnoff N, Lotfi K, Stenke L, Brümmendorf TH, Hjorth-Hansen H, Gedde-Dahl T, Majeed W, Burchert A, Nazarov PV, Felde E, Tarnopolscaia I, Hoelting C, Fabarius A, Hofmann WK, Mahon FX, Saussele S, Pfirrmann M. PMID: 42315627 [PubMed - as supplied by publisher]
	[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)]. Bull Cancer Delafoy M, Vincenti M, Roussel A, Prigent S, Rialland F, Doulet ST, Hauet Q, Broccia MV, Rabian F, Poirée M, Tabone MD, El-Louali F, Saultier P. PMID: 42315465 [PubMed - as supplied by publisher]
	Dosimetric evaluation of beam block techniques in helical tomotherapy for extranodal nasal-type NK/T-cell lymphoma. Med Dosim Zhu L, Zhang B, He Q, Yang G, Jin H, Li F, Meng H, Jian W, Wang X. PMID: 42315453 [PubMed - as supplied by publisher]
	Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial. J Nucl Med Tie X, Lee C, Perlman SB, Gowdy C, Shin M, Renfro LA, Kelly KM, McCarten KM, Alazraki AL, Voss SD, Alizadeh AA, Castellino SM, Bradshaw TJ, Cho SY. PMID: 42315307 [PubMed - as supplied by publisher]
	A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART). Jpn J Clin Oncol Kawabata K, Ohka F, Saito R, Onoe T, Harada H, Sasayama T, Yokoo H, Arakawa Y, Mizusawa J, Mitome N, Sasaki K, Fukuda H, Narita Y, Brain Tumor Study Group of the Japan Clinical Oncology Group. PMID: 42315131 [PubMed - as supplied by publisher]
	Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline. JCO Oncol Pract Lockwood CM, Messersmith HJ, Kim AS, Rajagopal PS, Swami U, Xian R, Aisner D, Arcila ME, Kurttila F, Lovly CM, Merker JD, Nair KG, Ntekim AI, Sheen MA, Tsimberidou AM, Turner NC, Gray SW. PMID: 42314080 [PubMed - as supplied by publisher]
	Anti-CD19 CAR-T in transformed indolent lymphoma versus de novo large B-cell lymphoma: a meta-analysis of 5,006 patients. Blood Adv Zhang MY, Lu KJ, Zhu XQ, Shen LJ, Du J. PMID: 42314038 [PubMed - as supplied by publisher]
	Diefenbach CS, Jegede O, Wang V, et al. A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma. Blood. 2026;147(18):2041-2052. Blood PMID: 42313436 [PubMed - in process]
	Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort Study. JACC Adv Filimon S, Ghamari A, Vakilpour A, Patel R, Achar R, Akhter N, Shallis RM, DeCara JM, Altman J, Smith A, Matthews A, Lai C, Brunner AM, Farina KA, Gilman HK, Neilan TG, Upadhyay D, Chittams J, Anazco F, Patel AA, Tremblay D, Scherrer-Crosbie M. PMID: 42312783 [PubMed]
	Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma. Haematologica Lee JY, Kim SA, Yang DH, Eum HS, Lee MW, Lee HJ, Kwak JY, Park YH, Do YR, Lee JO. PMID: 42312406 [PubMed - as supplied by publisher]
	Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study. Haematologica Gambacorti-Passerini C, Brümmendorf TH, Kim DW, Goh YT, Dyagil I, Pagnano K, Batai A, Turkina AG, Leip E, Purcell S, Leone J, Viqueira A, Cortes JE. PMID: 42312395 [PubMed - as supplied by publisher]
	Beyond the Surface: Duodenal-Type Follicular Lymphoma Diagnosed Despite Normal-Appearing Duodenal Mucosa and Absence of Focal Duodenal FDG Uptake. Case Rep Gastrointest Med Vinton Z, Schulz C, McGuire W, Hafeez S, Malik S. PMID: 42312190 [PubMed]
	Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy. Clinicoecon Outcomes Res Ghetti G, Castello L, Odonde LA, De Fazio S, Stella A, Bruno A, Marchionne E, Bonifacio M. PMID: 42311575 [PubMed]
	Real-world resource utilization, toxicity management, and efficacy outcomes of CD20â€‰Ã—â€‰CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network. Hemasphere Bastos-Oreiro M, Iacoboni G, Navarro V, Martínez C, Manresa P, Magnano L, Jiménez-Ubieto A, Vázquez S, Rodriguez MJ, Busnego MT, Del Campo R, Paúl PJ, Murillo I, Donato EM, Serna A, Luzardo H, Gómez P, Pérez E, Mendibil B, Ramos S, García-Noblejas A, Gonzalez de Villambrosia S, Díaz FJ, López J, Martín-Moro F, Fernandez-Caldas P, Fernandez R, Gutierrez A, Sánchez B, Domínguez N, Civeira M, Villafuerte P, Olazabal I, Zeberio I, Barrenetxea C, Gutierrez N, Romero S, Martín-Consuegra S, Huerga S, Golbano N, Riaza R, Hueso JA, Martinez-Barranco P, Navarro B, Villalón L, Ortega P, Torres A, Ormenazabal I, Sanchez Anton MP, Goñi MA, Abrisqueta P, Martín García-Sancho A. PMID: 42311429 [PubMed]
	Disseminated Tuberculosis Mimicking Metastatic Cancer During Ruxolitinib Therapy for Polycythemia Vera: A Case Report and Literature Review. Am J Case Rep Ono Y, Oka K, Ishikawa K, Shikata H, Kaneko M. PMID: 42310931 [PubMed - indexed for MEDLINE]
	BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88(L265P)-induced PIM1 stability. J Hematol Oncol Yuan Y, Dai B, Zhong H, Zheng J, Fan Z, Chen D, Wang Q, Wu H, Li Y, Zhu P, Ding T, Wang S, Wu K, Zhang Y, Wang Z, Feng R, Zhu F, Zheng K, Qin Z, Yang B, Chen H, Lin X, Yao Y, Zhuang D, Shi Z, Mao Y, Chen T. PMID: 42310786 [PubMed - indexed for MEDLINE]
	Cumulative incidence and prognostic factors for leukemic transformation in chronic myelomonocytic leukemia: a competing risk analysis. BMC Cancer Huang J, Zheng C, Liu Y, Li C, Xin X. PMID: 42310629 [PubMed - as supplied by publisher]
	BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia. Blood Cancer J Yan X, Feng G, Cai Z, Ma J, Xu S, Ge Z. PMID: 42310291 [PubMed - in process]
	TIM-3 as an immune and leukemia stem-cell biomarker in acute myeloid leukemia: diagnostic laboratory and translational perspectives. Clin Chim Acta Bhat AA, Fuloria S, Thapa R, Narain K, Bhatia S, Ansari MT, Agnihotri S, Wu YS, Meenakshi DU, Fuloria NK. PMID: 42309212 [PubMed - as supplied by publisher]
	Mutation-specific NPM1 immunohistochemistry is a sensitive method for detecting residual disease in mid- and postinduction bone marrows: comparison of NPM1 immunohistochemistry, NPM1 real-time polymerase chain reaction, and flow cytometric studies. Am J Clin Pathol Hong E, Bailey NG, Davis KE, Matsumoto NP, Moore EM, Rea B, Aggarwal N, Monaghan SA, Jawad M. PMID: 42309046 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 168376

Seite 1 von 8419

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung